Improving Natural Killer Cell Cancer Immunotherapy

Current Opinion in Organ Transplantation- United States

doi 10.1097/mot.0000000000000243

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Natural Killer T Cell Based Immunotherapy

Journal of Vaccines & Vaccination
2012English

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Frontiers in Immunology
AllergyImmunology
2015English

The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction

Cancers
Cancer ResearchOncology
2018English

Novel Targets for Natural Killer/T-Cell Lymphoma Immunotherapy

Immunotherapy
OncologyAllergyImmunology
2016English

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-Stimulatory Receptor Signaling for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2015English

Targeting Natural Killer Cells for Tumor Immunotherapy

Frontiers in Immunology
AllergyImmunology
2020English

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2017English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy